Current Drug Targets
Title: SUBJECT INDEX TO VOLUME 1
Volume: 2 Issue: 1
Author(s): Publishers Science Bentham
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers, SUBJECT INDEX TO VOLUME 1, Current Drug Targets 2001; 2 (1) . https://dx.doi.org/10.2174/1389450013349019
DOI https://dx.doi.org/10.2174/1389450013349019 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
9
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ultrasound Diagnostic Method in Vascular Dementia: Current Concepts
Current Medical Imaging Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets Subject Index to Volume 11
Protein & Peptide Letters β-Amyloid, Neuronal Death and Alzheimers Disease
Current Molecular Medicine Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design Chromosome 17 in Fronto Temporal Lobak Degeneration (FTLD): From MAPT to Progranulin and Back
Current Alzheimer Research Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Current Pharmaceutical Design Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Targeting Neurotrophin Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Hypercortisolemia and Glucocorticoid Receptor-Signaling Insufficiency in Alzheimer’ s Disease Initiation and Development
Current Alzheimer Research Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Current Medicinal Chemistry Peripheral Mononuclear Cell Rejuvenation for Senescence Surveillance in Alzheimer Disease
Current Pharmaceutical Design Advantages of Structure-Based Drug Design Approaches in Neurological Disorders
Current Neuropharmacology Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Current Neuropharmacology The Role of P-glycoprotein in Cerebral Amyloid Angiopathy; Implications for the Early Pathogenesis of Alzheimers Disease
Current Alzheimer Research Overview and Findings from the Rush Memory and Aging Project
Current Alzheimer Research Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Current Medicinal Chemistry Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
Current Alzheimer Research